PMC:7556165 / 2143-2346
Annnotations
LitCovid-sample-MedDRA
{"project":"LitCovid-sample-MedDRA","denotations":[{"id":"T6","span":{"begin":188,"end":202},"obj":"http://purl.bioontology.org/ontology/MEDDRA/10022891"}],"attributes":[{"id":"A6","pred":"meddra_id","subj":"T6","obj":"http://purl.bioontology.org/ontology/MEDDRA/10062026"}],"text":"Strategies aimed at blocking ACE2 with antibodies, small molecules or peptides, or at neutralizing the virus by competitive binding with exogenously administered ACE2, are currently under investigations."}
LitCovid-sample-CHEBI
{"project":"LitCovid-sample-CHEBI","denotations":[{"id":"T5","span":{"begin":70,"end":78},"obj":"Chemical"}],"attributes":[{"id":"A5","pred":"chebi_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/CHEBI_16670"}],"text":"Strategies aimed at blocking ACE2 with antibodies, small molecules or peptides, or at neutralizing the virus by competitive binding with exogenously administered ACE2, are currently under investigations."}
LitCovid-sample-sentences
{"project":"LitCovid-sample-sentences","denotations":[{"id":"T17","span":{"begin":0,"end":203},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Strategies aimed at blocking ACE2 with antibodies, small molecules or peptides, or at neutralizing the virus by competitive binding with exogenously administered ACE2, are currently under investigations."}
LitCovid-sample-Pubtator
{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"63","span":{"begin":29,"end":33},"obj":"Gene"},{"id":"64","span":{"begin":162,"end":166},"obj":"Gene"}],"attributes":[{"id":"A63","pred":"pubann:denotes","subj":"63","obj":"Gene:59272"},{"id":"A64","pred":"pubann:denotes","subj":"64","obj":"Gene:59272"}],"text":"Strategies aimed at blocking ACE2 with antibodies, small molecules or peptides, or at neutralizing the virus by competitive binding with exogenously administered ACE2, are currently under investigations."}
LitCovid-sample-UniProt
{"project":"LitCovid-sample-UniProt","denotations":[{"id":"T139","span":{"begin":29,"end":33},"obj":"Protein"},{"id":"T140","span":{"begin":162,"end":166},"obj":"Protein"}],"attributes":[{"id":"A139","pred":"uniprot_id","subj":"T139","obj":"https://www.uniprot.org/uniprot/Q9UFZ6"},{"id":"A140","pred":"uniprot_id","subj":"T140","obj":"https://www.uniprot.org/uniprot/Q9UFZ6"}],"text":"Strategies aimed at blocking ACE2 with antibodies, small molecules or peptides, or at neutralizing the virus by competitive binding with exogenously administered ACE2, are currently under investigations."}
LitCovid-sample-PD-IDO
{"project":"LitCovid-sample-PD-IDO","denotations":[{"id":"T10","span":{"begin":103,"end":108},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"}],"text":"Strategies aimed at blocking ACE2 with antibodies, small molecules or peptides, or at neutralizing the virus by competitive binding with exogenously administered ACE2, are currently under investigations."}
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"63","span":{"begin":29,"end":33},"obj":"Gene"},{"id":"64","span":{"begin":162,"end":166},"obj":"Gene"}],"attributes":[{"id":"A63","pred":"tao:has_database_id","subj":"63","obj":"Gene:59272"},{"id":"A64","pred":"tao:has_database_id","subj":"64","obj":"Gene:59272"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Strategies aimed at blocking ACE2 with antibodies, small molecules or peptides, or at neutralizing the virus by competitive binding with exogenously administered ACE2, are currently under investigations."}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T17","span":{"begin":0,"end":203},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Strategies aimed at blocking ACE2 with antibodies, small molecules or peptides, or at neutralizing the virus by competitive binding with exogenously administered ACE2, are currently under investigations."}